Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
Apple (NASDAQ:AAPL) – Apple will obtain an observer role on the OpenAI board as part of an AI agreement, with Phil Schiller chosen for the position. This arrangement will allow Schiller to...
Apple (NASDAQ:AAPL) – At today’s Apple Developer Conference (WWDC 2024) kicking off today, the company will demonstrate its prowess in the advanced field of artificial intelligence...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.4 | 1.15606936416 | 121.1 | 127.2 | 116 | 2552003 | 122.83335962 | CS |
4 | -12.07 | -8.96930965297 | 134.57 | 138.07 | 114.02 | 3354556 | 122.22752655 | CS |
12 | 13.95 | 12.8512206357 | 108.55 | 170.47 | 108.55 | 4081149 | 135.44128733 | CS |
26 | 22.25 | 22.1945137157 | 100.25 | 170.47 | 84.06 | 3864324 | 117.33158032 | CS |
52 | -4 | -3.16205533597 | 126.5 | 170.47 | 62.55 | 4235651 | 105.30754273 | CS |
156 | -196.5 | -61.5987460815 | 319 | 497.17 | 62.55 | 6343184 | 213.97759034 | CS |
260 | 108.28 | 761.462728551 | 14.22 | 497.17 | 11.54 | 8930360 | 148.17895745 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.